---
title: "First Ascent Biomedical opens FPM Cancer Lab in Miami, accepting patient referrals. Eligible colorectal cancer patients may qualify for sponsored testing."
description: "A laboratory in Miami is currently open to receiving referrals from patients and physicians. Residents of Florida, as well as colorectal cancer patients across the country, may be eligible for special"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/276059671.md"
published_at: "2026-02-16T13:10:14.000Z"
---

# First Ascent Biomedical opens FPM Cancer Lab in Miami, accepting patient referrals. Eligible colorectal cancer patients may qualify for sponsored testing.

> A laboratory in Miami is currently open to receiving referrals from patients and physicians. Residents of Florida, as well as colorectal cancer patients across the country, may be eligible for special programs covering the expenses of testing. On February 16, 2026, First Ascent Biomedical revealed the launch of these programs.

A laboratory in Miami is currently open to receiving referrals from patients and physicians. Residents of Florida, as well as colorectal cancer patients across the country, may be eligible for special programs covering the expenses of testing. On February 16, 2026, First Ascent Biomedical revealed the launch of these programs.

### Related Stocks

- [FBT.US - First Trust NYSE Arca Biotech Index Fd](https://longbridge.com/en/quote/FBT.US.md)
- [VHT.US - VG Health](https://longbridge.com/en/quote/VHT.US.md)
- [BBH.US - VanEck Biotech ETF](https://longbridge.com/en/quote/BBH.US.md)
- [PBM.US - Psyence Biomedical](https://longbridge.com/en/quote/PBM.US.md)
- [ARKG.US - Ark Genomic Revolution ETF](https://longbridge.com/en/quote/ARKG.US.md)
- [XBI.US - SPDR S&P Biotech](https://longbridge.com/en/quote/XBI.US.md)
- [PBE.US - Invesco Biotechnology & Genome ETF](https://longbridge.com/en/quote/PBE.US.md)
- [SBIO.US - ALPS Medical Breakthrough](https://longbridge.com/en/quote/SBIO.US.md)
- [IHE.US - iShares US Pharma](https://longbridge.com/en/quote/IHE.US.md)
- [IBB.US - iShares Biotechnology ETF](https://longbridge.com/en/quote/IBB.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Assetmark Inc. 出售了 18,236 股碩騰公司（Zoetis Inc.）的股票，股票代碼為$ZTS | Assetmark Inc. 在第三季度將其在 Zoetis Inc. (NYSE:ZTS) 的持股減少了 69.1%，出售了 18,236 股，剩餘 8,173 股，市值為 1,196,000 美元。其他機構投資者也調整了他們的持股。分析 | [Link](https://longbridge.com/en/news/276508320.md) |
| Madrigal 製藥因 Rezdiffra 的銷售，第四季度收入大幅增長 | Madrigal 製藥報告第四季度收入為 3.211 億美元，較去年大幅增長，儘管出現了淨虧損。該公司預計，由於疾病意識的提高，Rezdiffra 的銷售將實現強勁增長，並計劃與 FDA 就第二階段試驗設計進行諮詢。MASH 管道已通過新項 | [Link](https://longbridge.com/en/news/276330392.md) |
| 在樂觀的第四季度收益報告後，Kenvue 的分析師上調了他們的預測 | Kenvue Inc（紐約證券交易所代碼：KVUE）公佈了強勁的第四季度財報，每股收益為 27 美分，超過了 22 美分的預期，銷售額為 37.8 億美元，超出 36.81 億美元的預測。首席執行官 Kirk Perry 強調了嚴格的執行和 | [Link](https://longbridge.com/en/news/276259878.md) |
| 這位輝瑞分析師以看空的基調開始覆蓋；以下是週五的五大新啓動 | 華爾街頂級分析師已對多家公司啓動了覆蓋。Baird 的 David Koning 對 Affirm Holdings (AFRM) 給予中性評級，目標價為 55 美元。Piper Sandler 的 Biren Amin 對 OKYO Ph | [Link](https://longbridge.com/en/news/276467088.md) |
| Madrigal Pharmaceuticals, Inc. $MDGL 的股票被 Skandinaviska Enskilda Banken AB publ 購入 | 斯堪的納維亞銀行（Skandinaviska Enskilda Banken AB publ）在第三季度將其在 Madrigal Pharmaceuticals, Inc.（納斯達克代碼：MDGL）的持股增加了 361.6%，目前擁有 18 | [Link](https://longbridge.com/en/news/276321074.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.